VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 1 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $12,179 | +5.0% | 97,669 | -13.3% | 0.00% | – |
| Q4 2022 | $11,603 | +52640.9% | 112,646 | -22.2% | 0.00% | – |
| Q3 2022 | $22 | -96.3% | 144,832 | -78.7% | 0.00% | – |
| Q2 2022 | $598 | -99.9% | 679,596 | +3.6% | 0.00% | – |
| Q1 2022 | $813,000 | -65.0% | 655,782 | -45.0% | 0.00% | – |
| Q4 2021 | $2,324,000 | -47.8% | 1,191,461 | -26.6% | 0.00% | -100.0% |
| Q3 2021 | $4,450,000 | +141.5% | 1,624,246 | +177.7% | 0.00% | – |
| Q2 2021 | $1,843,000 | +279.2% | 584,902 | +156.2% | 0.00% | – |
| Q1 2021 | $486,000 | +198.2% | 228,308 | +171.2% | 0.00% | – |
| Q4 2020 | $163,000 | +64.6% | 84,175 | -40.5% | 0.00% | – |
| Q3 2020 | $99,000 | +94.1% | 141,356 | +1061.2% | 0.00% | – |
| Q3 2016 | $51,000 | – | 12,173 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,736,283 | $22,886,000 | 9.62% |
| VR Adviser, LLC | 16,047,286 | $31,292,000 | 4.28% |
| COMMODORE CAPITAL LP | 8,464,999 | $16,507,000 | 3.82% |
| Ghost Tree Capital, LLC | 2,000,000 | $3,900,000 | 1.40% |
| EPIQ PARTNERS, LLC | 1,002,350 | $1,955,000 | 1.04% |
| HighVista Strategies LLC | 577,031 | $1,125,000 | 0.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 4,024,938 | $7,849,000 | 0.86% |
| NEA Management Company, LLC | 16,302,596 | $31,790,000 | 0.64% |
| Nicholas Investment Partners, LP | 4,288,077 | $8,362,000 | 0.53% |
| Logos Global Management LP | 2,000,000 | $3,900,000 | 0.40% |